Xu G, Liang S, Hu G, Zhao W, et al. HDAC2 as a therapeutic target in bladder cancer: insights into the altered epigenetic regulation and lysine lactylation. J Exp Clin Cancer Res 2025 Dec 17. doi: 10.1186/s13046-025-03610.
PMID: 41408324